Physician profile
Steven A Levy
NPI 1407831126
$3,223.17
in general payments reported to CMS, 2019-2025
19 companies · $744 in 2025
The $744 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $938 · 2020: $244 · 2021: $127 · 2022: $377 · 2023: $426 · 2024: $366 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,452 · Debt Forgiveness: $84.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,451.80 |
| Debt Forgiveness | $84.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rikco International, LLC | $480.85 | 2019 | |
| Stryker Corporation | $445.55 | 2023-2025 | Ortholoc 2 Lapifuse, Infinity Adaptis, Citrefix |
| Amgen INC. | $379.48 | 2024-2025 | Krystexxa |
| Treace Medical Concepts, INC. | $349.47 | 2022-2025 | |
| Organogenesis INC. | $234.11 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $232.25 | 2019-2021 | |
| Kerecis Limited | $217.63 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbott Laboratories | $139.59 | 2023 | Proclaim |
| Nevro Corp. | $135.05 | 2022 | |
| Polarityte, INC. | $118.59 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $86.91 | 2022-2025 | Nuzyra |
| Djo, LLC | $84.72 | 2023 | |
| Boston Scientific Corporation | $63.13 | 2019 | |
| Fidia Pharma USA INC. | $58.33 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $51.81 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $51.62 | 2019 | |
| Orthofix Medical, INC. | $47.24 | 2024-2025 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $32.44 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.